Director of Policy & Advocacy, NTM Info & Research
A native of Canada, Amy moved to Miami, Florida to pursue her undergraduate studies and law degree at the University of Miami. She has more than 17 years’ experience in both the private and nonprofit sectors. Amy handles policy and legislative issues impacting NTMir, patients, or...
Read More →
Associate Director for Strategic Initiatives, CDER, FDA, United States
Dr. Mullin is Associate Center Director for Strategic Initiatives. She leads efforts including Patient-Focused Drug Development, Rare Disease Cures Accelerator, and CDER’s International Program. She leads the FDA delegation to ICH and currently chairs the ICH Management Committee...
Read More →
Chief Scientific Officer, Tuberous Sclerosis Alliance, United States
Steve leads the development and execution of the TS Alliance's scientific strategy through partnerships and conversations with stakeholders including individuals and families affected by TSC, basic and clinical researchers, healthcare providers, government agencies, and other non-profit...
Read More →
Director, Hyman, Phelps & McNamara, PC, United States
James Valentine, JD, MHS is an attorney at Hyman, Phelps & McNamara where he assists medical product industry and patient advocacy organization clients in a wide range of regulatory matters, including new drug and biologic development and approval issues. Mr. Valentine has been central...
Read More →